Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group
Titel:
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group
Auteur:
Fountzilas, G. Kalofonos, H.P. Dafni, U. Papadimitriou, C. Bafaloukos, D. Papakostas, P. Kalogera-Fountzila, A. Gogas, H. Aravantinos, G. Moulopoulos, L.A. Economopoulos, T. Pectasides, D. Maniadakis, N. Siafaka, V. Briasoulis, E. Christodoulou, C. Tsavdaridis, D. Makrantonakis, P. Razis, E. Kosmidis, P. Skarlos, D. Dimopoulos, M.A.